Ads
related to: fda, pharmaceuticalsthecountyoffice.com has been visited by 1M+ users in the past month
Search results
Robert Kennedy Jr. Is Sorry the FDA Didn't Approve Psychedelic Drug MDMA (Ecstasy or Molly) for PTSD...
Showbiz411· 2 days agoWhat is our potential next president worried about? Robert Kennedy Jr — just kidding– never to be...
FDA panel rejects MDMA therapy for treating patients with PTSD
WSB Radio· 3 days agoThe committee is comprised of independent mental health experts, The Washington Post reported. The...
West Pharmaceutical Services, Inc. (NYSE:WST): The Best Dividend Aristocrat Stock According to...
Insider Monkey via Yahoo Finance· 1 day agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
CNBC· 5 days agoCompany logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain...
Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?
Zacks· 3 days agoFree Report) . Will the recent negative trend continue leading up to its next earnings release, or is Rocket Pharmaceuticals due for a breakout? Before we dive into how investors ...
FDA Declines Approval Of MDMA As Treatment For PTSD
International Business Times· 2 days agoThe Food and Drug Administration has declined to recommend approval for the use of MDMA, more popularly known as molly or ecstasy, to treat...
Federal Circuit Upholds Rifaximin Patent Rulings, Affirms ANDA Approval Restrictions | JD Supra
JD Supra· 18 hours agoIn Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals, Inc. 2023-1952 (Fed. Cir. April 11, 2024), this case involves appellate review of a district ...
AI Integration In Drug Manufacturing: GMP Insights For Operational Excellence, Regulatory Compliance
BioresearchOnline· 4 days agoIn the pharmaceutical industry, the integration of artificial intelligence (AI) and machine learning...
ASCO: Jazz shares 'unprecedented' HER2 biliary tract cancer data ahead of FDA decision
FierceBiotech· 6 days agoAs zanidatamab awaits an FDA approval decision, Jazz Pharmaceuticals is sharing
FDA panel to review psychedelic drug MDMA for first time
Reuters· 4 days agoThe meeting by the agency's independent experts is the farthest that a drug based on MDMA, commonly...